Successful dose-intensive treatment of desmoplastic small round cell tumor in three children

Peter Kurre, Judy L. Felgenhauer, James S. Miser, Kathleen Patterson, Douglas S. Hawkins

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Desmoplastic small round cell tumor (DSRCT) is a rare soft tissue tumor of primitive origin occurring primarily in children and young adults. Based on published reports in the literature, the response to conventional chemotherapy is poor. We report three pediatric patients successfully treated with dose-intensive, multimodal therapy. Between August 1994 and March 1998, we evaluated three consecutive patients with DSRCT at Children's Hospital and Regional Medical Center, Seattle, Washington. We established the diagnosis based on clinical presentation, radiologic staging, and pathologic review with immunohistochemical staining. All patients received a combined modality protocol including dose-intensive chemotherapy (two of them with peripheral blood stem cell [PBSC] support), second look surgery, and consolidative local irradiation. The patients remain in continuous remission at 66, 42, and 26 months after diagnosis, respectively. Two of our patients were younger than any previously reported patient, extending the age group for which DSRCT should be considered on diagnosis of small round cell tumors. The uniform survival achieved in our series indicates potential benefit for the combination of dose-intensive multiagent chemotherapy, local irradiation, and aggressive surgical approach in this disease.

Original languageEnglish (US)
Pages (from-to)446-450
Number of pages5
JournalJournal of Pediatric Hematology/Oncology
Volume22
Issue number5
StatePublished - Sep 2000
Externally publishedYes

Fingerprint

Desmoplastic Small Round Cell Tumor
Drug Therapy
Therapeutics
Second-Look Surgery
Young Adult
Neoplasms
Age Groups
Pediatrics
Staining and Labeling
Survival

Keywords

  • Chemotherapy
  • Desmoplastic small round cell tumor
  • Dose intensification
  • G-CSF
  • PBSC support
  • Radiation therapy
  • Translocation t(11;22) (p13;q11.2)

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Kurre, P., Felgenhauer, J. L., Miser, J. S., Patterson, K., & Hawkins, D. S. (2000). Successful dose-intensive treatment of desmoplastic small round cell tumor in three children. Journal of Pediatric Hematology/Oncology, 22(5), 446-450.

Successful dose-intensive treatment of desmoplastic small round cell tumor in three children. / Kurre, Peter; Felgenhauer, Judy L.; Miser, James S.; Patterson, Kathleen; Hawkins, Douglas S.

In: Journal of Pediatric Hematology/Oncology, Vol. 22, No. 5, 09.2000, p. 446-450.

Research output: Contribution to journalArticle

Kurre, P, Felgenhauer, JL, Miser, JS, Patterson, K & Hawkins, DS 2000, 'Successful dose-intensive treatment of desmoplastic small round cell tumor in three children', Journal of Pediatric Hematology/Oncology, vol. 22, no. 5, pp. 446-450.
Kurre, Peter ; Felgenhauer, Judy L. ; Miser, James S. ; Patterson, Kathleen ; Hawkins, Douglas S. / Successful dose-intensive treatment of desmoplastic small round cell tumor in three children. In: Journal of Pediatric Hematology/Oncology. 2000 ; Vol. 22, No. 5. pp. 446-450.
@article{c21fe55d293c42faa3b976cd0d8e18d1,
title = "Successful dose-intensive treatment of desmoplastic small round cell tumor in three children",
abstract = "Desmoplastic small round cell tumor (DSRCT) is a rare soft tissue tumor of primitive origin occurring primarily in children and young adults. Based on published reports in the literature, the response to conventional chemotherapy is poor. We report three pediatric patients successfully treated with dose-intensive, multimodal therapy. Between August 1994 and March 1998, we evaluated three consecutive patients with DSRCT at Children's Hospital and Regional Medical Center, Seattle, Washington. We established the diagnosis based on clinical presentation, radiologic staging, and pathologic review with immunohistochemical staining. All patients received a combined modality protocol including dose-intensive chemotherapy (two of them with peripheral blood stem cell [PBSC] support), second look surgery, and consolidative local irradiation. The patients remain in continuous remission at 66, 42, and 26 months after diagnosis, respectively. Two of our patients were younger than any previously reported patient, extending the age group for which DSRCT should be considered on diagnosis of small round cell tumors. The uniform survival achieved in our series indicates potential benefit for the combination of dose-intensive multiagent chemotherapy, local irradiation, and aggressive surgical approach in this disease.",
keywords = "Chemotherapy, Desmoplastic small round cell tumor, Dose intensification, G-CSF, PBSC support, Radiation therapy, Translocation t(11;22) (p13;q11.2)",
author = "Peter Kurre and Felgenhauer, {Judy L.} and Miser, {James S.} and Kathleen Patterson and Hawkins, {Douglas S.}",
year = "2000",
month = "9",
language = "English (US)",
volume = "22",
pages = "446--450",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Successful dose-intensive treatment of desmoplastic small round cell tumor in three children

AU - Kurre, Peter

AU - Felgenhauer, Judy L.

AU - Miser, James S.

AU - Patterson, Kathleen

AU - Hawkins, Douglas S.

PY - 2000/9

Y1 - 2000/9

N2 - Desmoplastic small round cell tumor (DSRCT) is a rare soft tissue tumor of primitive origin occurring primarily in children and young adults. Based on published reports in the literature, the response to conventional chemotherapy is poor. We report three pediatric patients successfully treated with dose-intensive, multimodal therapy. Between August 1994 and March 1998, we evaluated three consecutive patients with DSRCT at Children's Hospital and Regional Medical Center, Seattle, Washington. We established the diagnosis based on clinical presentation, radiologic staging, and pathologic review with immunohistochemical staining. All patients received a combined modality protocol including dose-intensive chemotherapy (two of them with peripheral blood stem cell [PBSC] support), second look surgery, and consolidative local irradiation. The patients remain in continuous remission at 66, 42, and 26 months after diagnosis, respectively. Two of our patients were younger than any previously reported patient, extending the age group for which DSRCT should be considered on diagnosis of small round cell tumors. The uniform survival achieved in our series indicates potential benefit for the combination of dose-intensive multiagent chemotherapy, local irradiation, and aggressive surgical approach in this disease.

AB - Desmoplastic small round cell tumor (DSRCT) is a rare soft tissue tumor of primitive origin occurring primarily in children and young adults. Based on published reports in the literature, the response to conventional chemotherapy is poor. We report three pediatric patients successfully treated with dose-intensive, multimodal therapy. Between August 1994 and March 1998, we evaluated three consecutive patients with DSRCT at Children's Hospital and Regional Medical Center, Seattle, Washington. We established the diagnosis based on clinical presentation, radiologic staging, and pathologic review with immunohistochemical staining. All patients received a combined modality protocol including dose-intensive chemotherapy (two of them with peripheral blood stem cell [PBSC] support), second look surgery, and consolidative local irradiation. The patients remain in continuous remission at 66, 42, and 26 months after diagnosis, respectively. Two of our patients were younger than any previously reported patient, extending the age group for which DSRCT should be considered on diagnosis of small round cell tumors. The uniform survival achieved in our series indicates potential benefit for the combination of dose-intensive multiagent chemotherapy, local irradiation, and aggressive surgical approach in this disease.

KW - Chemotherapy

KW - Desmoplastic small round cell tumor

KW - Dose intensification

KW - G-CSF

KW - PBSC support

KW - Radiation therapy

KW - Translocation t(11;22) (p13;q11.2)

UR - http://www.scopus.com/inward/record.url?scp=0034265589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034265589&partnerID=8YFLogxK

M3 - Article

C2 - 11037858

AN - SCOPUS:0034265589

VL - 22

SP - 446

EP - 450

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 5

ER -